In the first VT-ablation trial of its kind in Asia and the first to offer insights for nonischemic cardiomyopathy, VT suppression and survival were superior when ablation preceded ICD implantation. Medscape Medical News
Enter your account data and we will send you a link to reset your password.
To use social login you have to agree with the storage and handling of your data by this website. %privacy_policy%Accept